O. Rascol

1.6k total citations
34 papers, 1.2k citations indexed

About

O. Rascol is a scholar working on Neurology, Neurology and Physiology. According to data from OpenAlex, O. Rascol has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 6 papers in Neurology and 5 papers in Physiology. Recurrent topics in O. Rascol's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Neurological disorders and treatments (6 papers). O. Rascol is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Botulinum Toxin and Related Neurological Disorders (8 papers) and Neurological disorders and treatments (6 papers). O. Rascol collaborates with scholars based in France, Austria and New Zealand. O. Rascol's co-authors include Jean‐Michel Sénard, A Rascol, Jean‐Louis Montastruc, Maryse Lapeyre‐Mestre, J L Montastruc, Sharada Rai, Christine Brefel, Anne Kästner, Étienne C. Hirsch and F. Javoy‐Agid and has published in prestigious journals such as Journal of Neurochemistry, Journal of Neurology Neurosurgery & Psychiatry and British Journal of Pharmacology.

In The Last Decade

O. Rascol

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Rascol France 15 874 258 196 154 135 34 1.2k
Silvana Tesei Italy 17 946 1.1× 292 1.1× 215 1.1× 204 1.3× 144 1.1× 24 1.6k
Birgit Herting Germany 21 809 0.9× 282 1.1× 84 0.4× 87 0.6× 125 0.9× 32 1.3k
E. Dupont Denmark 24 1.4k 1.6× 557 2.2× 97 0.5× 102 0.7× 235 1.7× 66 2.0k
Sven Pålhagen Sweden 17 803 0.9× 316 1.2× 73 0.4× 109 0.7× 126 0.9× 32 1.3k
Eduardo De Pablo‐Fernández United Kingdom 20 1.1k 1.2× 307 1.2× 84 0.4× 222 1.4× 135 1.0× 45 1.5k
Peter Valkovič Slovakia 20 786 0.9× 160 0.6× 89 0.5× 157 1.0× 104 0.8× 78 1.3k
Paolo Liberini Italy 21 353 0.4× 360 1.4× 169 0.9× 241 1.6× 69 0.5× 58 1.4k
Monique Galitzky France 16 1.0k 1.2× 457 1.8× 57 0.3× 132 0.9× 166 1.2× 21 1.3k
A Muratorio Italy 18 423 0.5× 236 0.9× 54 0.3× 113 0.7× 92 0.7× 68 1.0k
Talakad N. Sathyaprabha India 21 661 0.8× 259 1.0× 83 0.4× 134 0.9× 54 0.4× 42 1.1k

Countries citing papers authored by O. Rascol

Since Specialization
Citations

This map shows the geographic impact of O. Rascol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Rascol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Rascol more than expected).

Fields of papers citing papers by O. Rascol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Rascol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Rascol. The network helps show where O. Rascol may publish in the future.

Co-authorship network of co-authors of O. Rascol

This figure shows the co-authorship network connecting the top 25 collaborators of O. Rascol. A scholar is included among the top collaborators of O. Rascol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Rascol. O. Rascol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurevich, Tanya, et al.. (2025). Monitoring Parkinson’s Progression: Eye Movements vs. MDS-UPDRS III. Parkinsonism & Related Disorders. 134. 107389–107389. 1 indexed citations
2.
3.
Montastruc, Jean‐Louis, et al.. (2000). Adverse Drug Reactions to Selegiline[colon] A Review of the French Pharmacovigilance Database. Clinical Neuropharmacology. 23(5). 271–275. 38 indexed citations
4.
Andreu, Núria, Jean-Jacques Chalé, Jean‐Michel Sénard, et al.. (1999). L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.. PubMed. 22(1). 15–23. 64 indexed citations
5.
Jl, Montastruc, Michel Pelat, Patrick Verwaerde, et al.. (1998). Fluoxetine in orthostatic hypotension of Parkinson's disease: A clinical and experimental pilot study. Fundamental and Clinical Pharmacology. 12(4). 398–402. 14 indexed citations
6.
Sénard, Jean‐Michel, Sharada Rai, Maryse Lapeyre‐Mestre, et al.. (1997). Prevalence of orthostatic hypotension in Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 63(5). 584–589. 277 indexed citations
7.
Montastruc, Jean‐Louis, O. Rascol, & Jean‐Michel Sénard. (1996). The discovery of vasomotor nerves. Clinical Autonomic Research. 6(3). 183–187. 10 indexed citations
8.
Rascol, O., et al.. (1996). Ropinirole in the Treatment of Levodopa-Induced Motor Fluctuations in Patients with Parkinson's Disease. Clinical Neuropharmacology. 19(3). 234–245. 90 indexed citations
9.
Montastruc, Jean‐Louis, et al.. (1996). A study of tolerance to apomorphine. British Journal of Pharmacology. 117(5). 781–786. 22 indexed citations
10.
Sénard, Jean‐Michel, et al.. (1996). [Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years].. PubMed. 50(5). 425–7. 3 indexed citations
11.
Sénard, Jean‐Michel, et al.. (1994). [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].. PubMed. 150(11). 757–62. 31 indexed citations
12.
Sénard, Jean‐Michel, O. Rascol, Geneviève Durrieu, et al.. (1993). Effects of Yohimbine on Plasma Catecholamine Levels in Orthostatic Hypotension Related to Parkinson Disease or Multiple System Atrophy. Clinical Neuropharmacology. 16(1). 70–76. 50 indexed citations
13.
Fabre, Nelly, J L Montastruc, & O. Rascol. (1993). Alopecia. Clinical Neuropharmacology. 16(3). 266–268. 10 indexed citations
14.
Kästner, Anne, Étienne C. Hirsch, Olivier Lejeune, et al.. (1992). Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content?. Journal of Neurochemistry. 59(3). 1080–1089. 177 indexed citations
15.
Durrieu, Geneviève, et al.. (1992). Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment. Clinical Autonomic Research. 2(3). 153–157. 68 indexed citations
16.
Siè, Piérre, et al.. (1991). Locally activated coagulation induced by a peripheral endovenous catheter. Thrombosis Research. 64(6). 775–782. 1 indexed citations
17.
Agniel, Alain, Pierre Celsis, Gérard Viallard, et al.. (1991). Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.. Journal of Neurology Neurosurgery & Psychiatry. 54(9). 783–786. 18 indexed citations
18.
Sabatini, Umberto, O. Rascol, A Rascol, & Jean‐Louis Montastruc. (1990). Migraine Attacks Induced by Subcutaneous Apomorphine in Two Migrainous Parkinsonian Patients. Clinical Neuropharmacology. 13(3). 264–267. 12 indexed citations
19.
Clanet, Michel, Antoine Blancher, Patrick Calvas, & O. Rascol. (1989). Interferons and multiple sclerosis. Biomedicine & Pharmacotherapy. 43(5). 355–360. 8 indexed citations
20.
Montastruc, J L, O. Rascol, & A Rascol. (1989). A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.. Journal of Neurology Neurosurgery & Psychiatry. 52(6). 773–775. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Tesei Breakdown of academic impact, for papers by Birgit Herting Breakdown of academic impact, for papers by E. Dupont Breakdown of academic impact, for papers by Sven Pålhagen Breakdown of academic impact, for papers by Eduardo De Pablo‐Fernández Breakdown of academic impact, for papers by Peter Valkovič Breakdown of academic impact, for papers by Paolo Liberini Breakdown of academic impact, for papers by Monique Galitzky Breakdown of academic impact, for papers by A Muratorio Breakdown of academic impact, for papers by Talakad N. Sathyaprabha
Rankless by CCL
2026